| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Mycobacterium tuberculosis (3064 + rifampin-susceptible) |
- |
- |
0.025 － ? |
Rifabutin (Mycobutin)  |
1078 |
| Mycobacterium tuberculosis (3064 + rifampin-susceptible) |
- |
- |
0.1 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (3064 + rifampin-susceptible) |
- |
- |
0.2 － ? |
Rifampicin (Rifampin) |
1078 |
| Mycobacterium tuberculosis (31 + rifampin-susceptible) |
- |
- |
0.1 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (31 + rifampin-susceptible) |
- |
- |
0.2 － ? |
Rifabutin (Mycobutin) |
1078 |
| Mycobacterium tuberculosis (31 + rifampin-susceptible) |
- |
- |
0.2 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (31 + rifampin-susceptible) |
- |
- |
0.2 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (31 + rifampin-susceptible) |
- |
- |
>51.2 － ? |
Rifampicin (Rifampin) |
1078 |
| Mycobacterium tuberculosis (3113 + rifampin-susceptible) |
- |
- |
0.006 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3113 + rifampin-susceptible) |
- |
- |
0.05 － ? |
Rifabutin (Mycobutin) |
1078 |
| Mycobacterium tuberculosis (3113 + rifampin-susceptible) |
- |
- |
0.05 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3113 + rifampin-susceptible) |
- |
- |
0.05 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (3113 + rifampin-susceptible) |
- |
- |
0.1 － ? |
Rifampicin (Rifampin) |
1078 |
| Mycobacterium tuberculosis (3125 + rifampin-susceptible) |
- |
- |
0.012 － ? |
Rifabutin (Mycobutin) |
1078 |
| Mycobacterium tuberculosis (3125 + rifampin-susceptible) |
- |
- |
0.012 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3125 + rifampin-susceptible) |
- |
- |
0.025 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3125 + rifampin-susceptible) |
- |
- |
0.05 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (3125 + rifampin-susceptible) |
- |
- |
0.1 － ? |
Rifampicin (Rifampin) |
1078 |
| Mycobacterium tuberculosis (3147 + rifampin-susceptible) |
- |
- |
0.003 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3147 + rifampin-susceptible) |
- |
- |
0.006 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (3147 + rifampin-susceptible) |
- |
- |
0.012 － ? |
Rifabutin (Mycobutin) |
1078 |
| Mycobacterium tuberculosis (3147 + rifampin-susceptible) |
- |
- |
0.025 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (3147 + rifampin-susceptible) |
- |
- |
0.05 － ? |
Rifampicin (Rifampin) |
1078 |
| Mycobacterium tuberculosis (33 + rifampin-susceptible) |
- |
- |
0.05 － ? |
Rifabutin (Mycobutin) |
1078 |
| Mycobacterium tuberculosis (33 + rifampin-susceptible) |
- |
- |
0.05 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (33 + rifampin-susceptible) |
- |
- |
0.1 － ? |
Rifalazil (ABI-1648, KRM-1648) |
1078 |
| Mycobacterium tuberculosis (33 + rifampin-susceptible) |
- |
- |
0.1 － ? |
T9 |
1078 |
| Mycobacterium tuberculosis (33 + rifampin-susceptible) |
- |
- |
12.8 － ? |
Rifampicin (Rifampin) |
1078 |